Key results (12mg): 28.3% average weight loss (70.3 lbs)
Alongside an expanding pipeline, innovation is accelerating through new mechanisms of action (e.g., GIP/GLP-1 dual agonists, amylin analogs, and small molecules like orforglipron) and diversified routes of administration such as orals and ultra-long acting injectables
Heart failure can also be caused by myocardial infarction, hypertension, diseases of the heart valves, cardiomyopathy, and congenital heart diseases
Second, the combination of GLP-1 medication with testosterone optimization creates a treatment approach that is uniquely relevant to men dealing with weight gain and declining hormonal levels simultaneously
Position the pen at the injection site you chose earlier, making sure not to cover the dose window with your hand